Smith & Nephew Receives 501k Clearance to Claim 30-Year Performance With VERILAST Technology

Smith & Nephew has received 501k clearance from the Food and Drug Administration to market its LEGION knee replacement, with VERILAST technology, as having a 30-year lifespan, according to a Smith & Nephew news release.

Advertisement

After simulating 30 years of physical activity on the company’s LEGION knee replacement, VERILAST technology produced an 81-percent reduction in wear, according to the release. The consensus of scientific literature is that knee implants are expected to last 10 to 15 years.

The FDA reviewed the results of the study and granted Smith & Nephew clearance to market the LEGION knee replacement as being able to “provide wear performance sufficient for 30 years of actual use under typical conditions,” according to the release.

Read Smith & Nephew’s release on the LEGION knee replacement 501k clearance.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.